what is active surveillance, and who would it be appropriate for?
Published 2 years ago • 755 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
1:56
active surveillance for kidney cancer
-
6:54
david chen, md, facs: active surveillance for low-risk renal tumors
-
26:50
renal mass biopsy, active surveillance and follow up strategies by craig rogers, m.d.
-
12:19
active surveillance 2022: who qualifies, who does not and how should it be monitored
-
23:37
active surveillance who is the right patient and what is the right protocol
-
31:10
evaluation and management of the small renal mass, surena f. matin, md
-
10:30
renal mass and localized renal cancer: active surveillance and follow up after intervention
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
58:06
update on the management of localized renal tumors
-
22:40
active surveillance for small renal masses
-
11:00
renal mass and localized renal cancer evaluation and management
-
28:59
evaluation and management of localized renal cell carcinoma - surena f. matin, md, facs
-
0:29
who is at risk for kidney cancer and can it be prevented?
-
1:00:12
vps 2021: genetics and kidney cancer
-
1:59:07
kidney cancer association
-
1:00:20
an insider's look - innovations in bladder and kidney cancer treatment
-
1:25:04
#kcrs20: emerging biomarkers for kidney cancer
-
20:23
active surveillance criteria and follow-up protocol
-
30:39
into the light: understanding and treating rare kidney cancers